TD Asset Management’s Taysha Gene Therapies TSHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-175,600
Closed -$393K 1428
2024
Q2
$393K Hold
175,600
﹤0.01% 1301
2024
Q1
$504K Hold
175,600
﹤0.01% 1295
2023
Q4
$311K Hold
175,600
﹤0.01% 1338
2023
Q3
$555K Buy
+175,600
New +$555K ﹤0.01% 1260